Literature DB >> 24531173

For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features.

Manuela Fogli1, Marialuisa Iaria, Emanuele Focá, Cinzia Giagulli, Francesca Caccuri, Fabrizio Maggi, Carlo Torti, Arnaldo Caruso, Simona Fiorentini.   

Abstract

There is disagreement on the optimal timing of HAART initiation based on absolute CD4+ T-cell count (CD4+ count). We investigated if na�ve patients with CD4+ T-cell percentage (%CD4+) <29% or CD4+/CD8+ ratio <1 display signs of immune deterioration notwithstanding CD4+ count ?500 cells/?l. We found that these patients show B-cell aberrations and an impaired control of Torque Teno Virus replication. By contrast, patients with CD4+?500/?l, %CD4+?29% and CD4+/CD8+?1 displayed features of healthy subjects. Results obtained suggest that a combination of these parameters could be an adequate surrogate marker of immunological competence. This will be helpful in deciding when to start HAART.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531173

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  2 in total

1.  Absolute CD4+ T cell count overstate immune recovery assessed by CD4+/CD8+ ratio in HIV-infected patients on treatment.

Authors:  Yusnelkis Milanés-Guisado; Alicia Gutiérrez-Valencia; María Trujillo-Rodríguez; Nuria Espinosa; Pompeyo Viciana; Luis Fernando López-Cortés
Journal:  PLoS One       Date:  2018-10-22       Impact factor: 3.240

2.  Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).

Authors:  Jose-Ramon Blanco; Belen Alejos; Santiago Moreno
Journal:  PLoS One       Date:  2020-01-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.